Here, we examined a cohort of 149 convalescent individuals who had confirmed infection with SARS-CoV-2 and their close contacts who had measurable plasma neutralizing activity to investigate the contribution of IgA to anti–SARS-CoV-2 antibody response. This evidence concerns the gene CD79A and infection.